Po-Lin Lin

Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2

Min‐Che Tung, Po-Lin Lin, Yao-Chen Wang et al. · Oncotarget · 2015 · 136 citations · Full text

Cisplatin Resistance, Tumor Biology, Oncogenic Agent +15

IL-10 Promotes Tumor Aggressiveness via Upregulation of CIP2A Transcription in Lung Adenocarcinoma

Wen‐Wei Sung, Yao-Chen Wang, Po-Lin Lin et al. · Clinical Cancer Research · 2013 · 74 citations

MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc

Tsang-Chi Lin, Po-Lin Lin, Ya‐Wen Cheng et al. · Annals of Surgical Oncology · 2015 · 56 citations

Oncology, Poor Outcomes, Medicine +10

MicroRNA-21 promotes tumour malignancy via increased nuclear translocation of β-catenin and predicts poor outcome in APC-mutated but not in APC-wild-type colorectal cancer

Po-Lin Lin, De‐Wei Wu, Chi-Chou Huang et al. · Carcinogenesis · 2014 · 54 citations · Full text

Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2

Min‐Che Tung, Po-Lin Lin, Ya‐Wen Cheng et al. · Oncotarget · 2016 · 53 citations · Full text